Dalle Carbonare, L., Bertoldo, F., & Lo Cascio, V. (1). Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project. Reumatismo, 61(1), 54-64. https://doi.org/10.4081/reumatismo.2009.54